Michael has served as the Goldman Sachs global medical advisor as well as an independent consultant since July, 2022 when he retired from the firm. Michael served as global head of Benefits and Wellness at Goldman Sachs until 2019 and as global Medical Director until 2022. He joined Goldman Sachs in 2009 as US medical director and was named managing director in 2013.

Prior to joining the firm, Michael was medical director at Merrill Lynch from 2007 to 2009. Previously, he was a physician in private practice in Manhattan from 1990 to 2007, specializing in internal medicine and infectious diseases. During that time, Michael also served as a medical consultant at Merrill Lynch.

He serves on the board of the Northeast Business Group on Health. He is also currently on the board of the GeoSentinel Foundation, a nonprofit organization that funds research in emerging infectious diseases. From 2009 to 2017, Michael also served on the board of Fedcap, a nonprofit that works to remove barriers to employment for the disabled and disadvantaged.

Michael earned a BA in Biology from Brown University in 1979 and an MD from the University of Maryland in 1984. He completed his training in Internal Medicine at Medical College of Pennsylvania in 1987 and in Infectious Diseases at New York University in 1990.